Clinical Trials Logo

Bowel Dysfunction clinical trials

View clinical trials related to Bowel Dysfunction.

Filter by:

NCT ID: NCT06377280 Recruiting - Bowel Dysfunction Clinical Trials

En Evaluation of Navina Mini, a New Low-volume Transanal Irrigation Device.

Start date: January 18, 2024
Phase: N/A
Study type: Interventional

This is an un-controlled, prospective, multi center, post market clinical follow-up investigation that will enroll male and female subjects in need of bowel management with low-volume transanal irrigation (TAI) as judged by the investigator. A total of 40 investigational subjects in need of low-volume TAI will be recruited from 2-3 sites in Sweden and will be treated with Navina Mini as per product intended purpose and per instruction of use during a period of four weeks. Participating subjects will perform three visits during the clinical investigation and will be followed for a total of four weeks. The first visit, Visit 1, will be performed at the investigational clinic to assess eligibility, collect demographics, baseline data and instruct how to use the device. Visit 2 will be performed after two weeks of treatment through telephone contact. The final visit, Visit 3, will be performed after additional two weeks of treatment, and can be performed either at the investigational clinic or through telephone contact.

NCT ID: NCT06315179 Not yet recruiting - Ulcerative Colitis Clinical Trials

Seattle Spatial Transcriptomic Research in Inflammatory Bowel Disease Evaluation (STRIDE)

STRIDE
Start date: April 2024
Phase:
Study type: Observational [Patient Registry]

This is a prospective observational study collecting long-term clinical data and samples for research in pediatric inflammatory bowel disease (IBD) patients with gut inflammation and a control cohort of pediatric patients with disorders of the brain-gut interactions (DBGI) with no detectable gut inflammation.

NCT ID: NCT06311110 Active, not recruiting - Clinical trials for Lower Urinary Tract Symptoms

Impaired Toilet Training, LUTS and Bowel Dysfunction in Children With DCD

Start date: October 30, 2023
Phase:
Study type: Observational

This cross-sectional case-control study aimed to determine whether there is a significant difference in the prevalence of impaired toilet training, LUTS, and functional bowel problems among children diagnosed with DCD and typically developing children (TDC).

NCT ID: NCT06288464 Recruiting - Bowel Dysfunction Clinical Trials

Enteral Feeding of Fibre to Improve Microbiota

Start date: January 9, 2023
Phase: N/A
Study type: Interventional

Following surgical removal of diseased bowel, patients often require a temporary redirection of bowel contents to a stoma, to allow healing prior to re-joining of the remaining bowel at a later date. Some patients may experience complications, either during or after reversal surgery, and this may be due to changes in the 'friendly' bacteria that live in our bowels. Previous research shows that the distal section of bowel that is non-functioning undergoes tissue-wasting and the 'friendly' bacteria that help our digestion die. Data shows that patients that have a reduction in their microflora are more likely to experience side effects. This study investigates a method of replenishing the microflora prior to surgery.

NCT ID: NCT06252714 Not yet recruiting - Clinical trials for Pelvic Organ Prolapse

Impact of Defecation Posture on Ease of Bowel Movements in Patients With a Rectocele

Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The study aims to determine if defecation posture, when using a defecation posture modification device (DPMD), will improve ease of bowel movements in patients with pelvic organ prolapse, specifically rectoceles.

NCT ID: NCT05880446 Active, not recruiting - Prostate Cancer Clinical Trials

PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)

PROCAR-BQ
Start date: October 6, 2023
Phase: N/A
Study type: Interventional

This is a prospective pilot study to evaluate the mean increase of bowel symptoms after pelvic radiotherapy (RT) in prostate cancer (PCa) patient using the validated & newly translated EORTC-QLQ PRT20 module.

NCT ID: NCT05716230 Recruiting - Bowel Dysfunction Clinical Trials

Bowel Function and Associated Risk Factors for Bowel Dysfunciton in Patients With Anorectal Malformation

Start date: November 20, 2022
Phase:
Study type: Observational

The present study was designed to evaluate bowel function in preschool and early childhood in a large number of patients with anorectal Malformation and to identify the associated risk factors for bowel dysfunction.

NCT ID: NCT05655845 Recruiting - Constipation Clinical Trials

Risk Factors for Bowel Dysfunction at Preschool and Early Childhood Age in Children With Hirschsprung Disease

Start date: August 20, 2022
Phase:
Study type: Observational

Bowel dysfunction has been proven as the most common complication after pull-through(PT) of Hirschsprung disease(HD) ,which may persist to adulthood and lead to social problems.The reason of bowel dysfunction is complicated and the risk factors were not defined.

NCT ID: NCT05644912 Recruiting - Bowel Dysfunction Clinical Trials

Exploratory Investigation on a Novel Catheter

Start date: November 18, 2022
Phase: N/A
Study type: Interventional

An exploratory, pre-market, open, prospective, interventional, clinical investigation at a limited number of centers for proof of concept of a new catheter. In this proof of concept investigation, subjects experienced in using transanal irrigation (TAI) with a balloon catheter will be using study catheters at two occasions to primarily study if the catheter will stay in place during the water instillation when performing TAI. Each subject will be followed during approximately one week, depending on the usual time between their TAI.

NCT ID: NCT05380856 Recruiting - Multiple Sclerosis Clinical Trials

Sacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction

Start date: September 26, 2023
Phase: N/A
Study type: Interventional

A multi-center double-blinded placebo-controlled randomized clinical trial. The patients will be randomized into two groups. To investigate the efficacy of SNM to improve the key bladder diary variables compared to placebo (i.e. sham) for patients with MS having refractory neurogenic lower urinary tract dysfunction (NLUTD). After first step SNM-procedure and a 3-4 weeks test period patients with more than 50% improvement in the key bladder diary variables will have the IPG implanted. After a month of optimization patients will into two groups: IPG ON or IPG OFF. Period of randomization: four months. Number anticipated to be included: 60 patients